LGALS1 and lung cancer: Galectin-1 has been shown to promote lung cancer metastasis by increasing levels of Notch and its ligand, Jagged2, while enhancing AKT activation, promoting tumorigenesis and invasiveness, and is associated with a poor prognosis in lung adenocarcinoma [17,18].